logo

For the Inventor, By the Inventor

Taipei, Taiwan

Hsu-Shan Huang

This inventor holds 21 USPTO granted patents and 1 published patent application, plus 1 CIPO patent, primarily in Pharmaceutical Chemistry. Top assignees: National Defense Medical Center, Dr. Keith Chan, Globoasia, LLC, Keith Chan, President Globoasia, LLC. Active years: 1998-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hsu-Shan Huang. Retrieved from https://idiyas.com/inventor/hsu-shan-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 47.6


Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:

goldMedal16 out of 50 
 
National Defense Medical Center
 patents
silverMedal1 out of 1 
 
Dr. Keith Chan, Globoasia, LLC
 patent
bronzeMedal1 out of 1 
 
Keith Chan, President Globoasia, LLC
 patent
4. 1 out of 2 
 
National Defense Medical University
 patents
5. 1 out of 505 
 
Teva Pharmaceutical Industries Limited
 patents
6. 1 out of 834,513 
Other
 patents

Years Active: 1998-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Renal Fibrosis
Anthraquinone Derivatives
Cancer Inhibition
Biphenyl Benzamide
Pharmaceutical Composition
Heterocyclic Compounds
Synthesis Methods
Small Molecules
Cytotoxic Evaluation
Telomere Growth
Lipid Peroxidation
21 patents (USPTO):Explore Patents
1. 12478632 - Method for ameliorating progression of renal fibrosis and treating renal fibrosis by 5-(2',4′-difluorophenyl)-salicylanilide derivatives (2025-11-25),
2. 9162993 - Preparation and pharmaceuticals of biphenyl benzamide-derived derivatives (2015-10-20),
3. 9018203 - Pharmaceutical composition of salicylanilide-derived small molecules and preparation and application thereof (2015-04-28),
4. 8975255 - Preparation and pharmaceuticals of biphenyl benzamide-derived derivatives (2015-03-10),
5. 8927717 - [object Object] (2015-01-06),
6. 8877748 - Heterocyclic fused anthraquinone derivatives, manufacturing method and pharmaceutical composition using thereof (2014-11-04),
7. 8772344 - Pharmaceutical composition for inhibiting osteoclast growth (2014-07-08),
8. 8772321 - Heteroannelated anthraquinone derivatives for inhibiting cancers (2014-07-08),
9. 8530465 - 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof (2013-09-10),
10. 8470824 - Substituted naphto[2,3-f]quinoxaline-7,12-diones and pharmaceutical utility thereof (2013-06-25),
11. 8445492 - Method for inhibiting growth of cancer cells and cell telomere and diseases of cell proliferation by using heteroannelated anthraquinone derivative compounds (2013-05-21),
12. 8410161 - Thioxanthone ring system derivatives (2013-04-02),
13. 8304415 - 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof (2012-11-06),
14. 8222287 - Substituted anthra[1,2-D]imidazolediones and pharmaceutical utility thereof (2012-07-17),
15. 8124637 - Anthra [1, 2-d]imidazole-6,11-dione derivatives, preparation method and application thereof (2012-02-28),

Title: Hsu-Shan Huang: Innovator in Pharmaceutical Chemistry

Introduction

Hsu-Shan Huang is a prominent inventor based in Taipei, Taiwan, recognized for his significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of 20 patents, his innovative work focuses on the development of advanced pharmaceutical compounds aimed at improving therapeutic outcomes.

Latest Patents

Among his latest inventions, Hsu-Shan Huang has developed a patent titled "Preparation and Pharmaceuticals of Biphenyl Benzamide-Derived Derivatives." This invention encompasses a unique structure chosen from formula I or formula II, including its synthesis and applications. Another notable patent from Huang is "Pharmaceutical Composition of Salicylanilide-Derived Small Molecules and Preparation and Application Thereof." This patent highlights a pharmaceutical composition that comprises salicylanilide-derived small molecules, showcasing his commitment to advancing medical science through innovative solutions.

Career Highlights

Huang has made significant strides in his career, particularly during his tenure at the National Defense Medical Center. His role there has allowed him to explore and innovate in areas crucial to pharmaceutical development, ultimately leading to the registration of multiple patents that contribute to both military and civilian healthcare.

Collaborations

Throughout his career, Hsu-Shan Huang has collaborated with esteemed colleagues, including Chia-Chung Lee and Deh-Ming Chang. These partnerships have greatly enriched his research endeavors, fostering an environment where groundbreaking ideas and innovative solutions can flourish.

Conclusion

Hsu-Shan Huang stands out as a leading inventor in Taipei, Taiwan, with a focus on pharmaceutical innovations that have the potential to impact public health significantly. His continued work showcases the vital role of inventors in the advancement of science and technology, making important strides toward effective therapeutic solutions for various health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…